Hikaru Ota

Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration

Hikaru Ota, Jun Takeuchi, Yuyako Nakano et al. · Japanese Journal of Ophthalmology · 2022 · 30 citations

Ocular Disease, Ophthalmology, Experimental Ophthalmology +4

Electrochemical oxidation of ammonia by multi-wall-carbon-nanotube-supported Pt shell–Ir core nanoparticles synthesized by an improved Cu short circuit deposition method

Seitaro Morita, Eiji Kudo, Ryo Shirasaka et al. · Journal of Electroanalytical Chemistry · 2015 · 26 citations

Materials Science, Chemical Engineering, Engineering +6

Aqueous Humor Cytokine Analysis in Age-Related Macular Degeneration After Switching From Aflibercept to Faricimab

Takahito Todoroki, Jun Takeuchi, Hikaru Ota et al. · Investigative Ophthalmology & Visual Science · 2024 · 14 citations · Full text

Predictive factors for outcomes of half-dose photodynamic therapy combined with aflibercept for pachychoroid neovasculopathy

Jun Takeuchi, Hikaru Ota, Yuyako Nakano et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2023 · 11 citations

Ophthalmology, Photodynamic Therapy, Predictive Factors +9